Polar Asset Management Partners’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Polar Asset Management Partners’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-81,000	Closed	-$2.11M	–	467
2019 Q1	$2.11M	Buy	+81,000	New	+$1.51M	0.05%	207

Polar Asset Management Partners's CMTA Position: Q2 2019 in Review

Polar Asset Management Partners sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 81,000 shares — an estimated $2.11M sold.

Polar Asset Management Partners first reported a position in CMTA in Q1 2019 and held it in 1 quarter. The position peaked at $2.11M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

Polar Asset Management Partners reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
Polar Asset Management Partners sold 81,000 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $2.11M.
Polar Asset Management Partners first reported a position in Clementia Pharmaceuticals Inc. in Q1 2019 and held it in 1 quarter.
Polar Asset Management Partners's Clementia Pharmaceuticals Inc. position peaked at $2.11M in Q1 2019.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Polar Asset Management Partners's 13F filing for Q2 2019, filed 14 Aug 2019.